EGFR and non-small cell lung carcinoma: It has been thought that apatinib could enhance efficacy of EGFR-TKIs in advanced NSCLC, however, whether prior use of EGFR-TKIs makes positive influence on efficacy of apatinib and contributes to our patient's long PFS are still unclear and need to be confirmed in the future.